Furthermore, gain-of-function assays were further explored that pseudogene CTNNAP1 could act as a ceRNA to increase CTNNA1 gene expression through competition for microRNA-141, subsequently inhibiting cell proliferation and tumor growth. The gene discussed is CTNNA1; the disease is neoplasm.